{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:48:29Z","timestamp":1788382109427,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T00:00:00Z","timestamp":1639353600000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001165"],"award-info":[{"award-number":["82001165"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Talent Cultivation Project of the Third xiangya hospital of Central South University","award":["BJ202101"],"award-info":[{"award-number":["BJ202101"]}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","award":["2021JJ31002"],"award-info":[{"award-number":["2021JJ31002"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2021JJ40926"],"award-info":[{"award-number":["2021JJ40926"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Changsha Municipal Natural Science Foundation","award":["kq2007056"],"award-info":[{"award-number":["kq2007056"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Clinically, steroid-resistant nephrotic syndrome (SRNS) is always prolonged and difficult to treat and easily develops into end-stage renal disease, resulting in a low survival rate. Strategies to reverse steroid resistance and reduce the long-term use of high doses of steroid medicines are urgently needed. In this study, a novel nanoparticle drug system (Pm-GCH) with a core\u2013shell structure was designed. Metal\u2013organic frameworks, synthesized by glycyrrhizic acid (G) and calcium ions (Ca<jats:sup>2+<\/jats:sup>) loaded with hydrocortisone (H) were the core of the nanoparticles. Platelet membrane vesicles were the shells. The natural platelet membrane endows Pm-GCH with good biocompatibility and the ability to promote immune escape. In addition, under the chemotaxis of inflammatory factors, platelet membranes assist Pm-GCH in nonspecific targeting of the inflammatory sites of the kidney. Under an inflammatory acid environment, GCH slowly degrades and releases glycyrrhizic acid and hydrocortisone. Glycyrrhizic acid inhibits the inactivation of hydrocortisone, jointly inhibits the activity of phospholipase A2 (PLA2) and the classic activation pathway of complement C2, blocks the production of inflammatory factors, plays an anti-inflammatory role, and enhances the efficacy of hydrocortisone in the treatment of SRNS. Moreover, glycyrrhizic acid alleviates osteoporosis induced by long-term use of glucocorticoids. These results indicate that Pm-GCH is a promising treatment strategy for SRNS.<\/jats:p><jats:p><jats:bold>Graphical Abstract<\/jats:bold><\/jats:p>","DOI":"10.1186\/s12951-021-01165-z","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T14:03:56Z","timestamp":1639404236000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["A novel biomimetic nanomedicine system with anti-inflammatory and anti-osteoporosis effects improves the therapy efficacy of steroid-resistant nephrotic syndrome"],"prefix":"10.1186","volume":"19","author":[{"given":"Jian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinying","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingnan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2501-0507","authenticated-orcid":false,"given":"Rong","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,13]]},"reference":[{"issue":"1","key":"1165_CR1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrneph.2017.155","volume":"14","author":"S Agrawal","year":"2018","unstructured":"Agrawal S, Zaritsky JJ, Fornoni A, Smoyer WE. Dyslipidaemia in nephrotic syndrome: mechanisms and treatment. Nat Rev Nephrol. 2018;14(1):57\u201370.","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"1165_CR2","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1681\/ASN.2018080786","volume":"30","author":"F Zhao","year":"2019","unstructured":"Zhao F, Zhu J, Richman A, Fu Y, Huang W, Chen N, et al. Mutations in are implicated in steroid-resistant nephrotic syndrome. J Am Soc Nephrol. 2019;30(5):840\u201353.","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"1165_CR3","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41574-020-0341-0","volume":"16","author":"P Chotiyarnwong","year":"2020","unstructured":"Chotiyarnwong P, McCloskey E. Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment. Nat Rev Endocrinol. 2020;16(8):437\u201347.","journal-title":"Nat Rev Endocrinol"},{"issue":"14","key":"1165_CR4","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJMc1901239","volume":"380","author":"M Sosa","year":"2019","unstructured":"Sosa M, G\u00f3mez de Tejada M. Glucocorticoid-induced osteoporosis. N Engl J Med. 2019;380(14):1378\u20139.","journal-title":"N Engl J Med"},{"issue":"1","key":"1165_CR5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12881-018-0714-6","volume":"19","author":"A Siji","year":"2018","unstructured":"Siji A, Karthik KN, Pardeshi VC, Hari PS, Vasudevan A. Targeted gene panel for genetic testing of south Indian children with steroid resistant nephrotic syndrome. BMC Med Genet. 2018;19(1):200.","journal-title":"BMC Med Genet"},{"issue":"1","key":"1165_CR6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2215\/CJN.06060519","volume":"15","author":"S Landini","year":"2020","unstructured":"Landini S, Mazzinghi B, Becherucci F, Allinovi M, Provenzano A, Palazzo V, et al. Reverse phenotyping after whole-exome sequencing in steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol. 2020;15(1):89\u2013100.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"1165_CR7","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/epi.13703","volume":"58","author":"C Ghosh","year":"2017","unstructured":"Ghosh C, Hossain M, Solanki J, Najm IM, Marchi N, Janigro D. Overexpression of pregnane X and glucocorticoid receptors and the regulation of cytochrome P450 in human epileptic brain endothelial cells. Epilepsia. 2017;58(4):576\u201385.","journal-title":"Epilepsia"},{"key":"1165_CR8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.17116\/oftalma2020136062125","volume":"136","author":"A Brovkina","year":"2020","unstructured":"Brovkina A, Sychev D, Toropova O. Influence of CYP3A4, CYP3A5, and NR3C1 genes polymorphism on the effectiveness of glucocorticoid therapy in patients with endocrine ophthalmopathy. Vestn oftalmol. 2020;136:125\u201332.","journal-title":"Vestn oftalmol"},{"key":"1165_CR9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ijpharm.2019.01.047","volume":"559","author":"OY Selyutina","year":"2019","unstructured":"Selyutina OY, Polyakov NE. Glycyrrhizic acid as a multifunctional drug carrier\u2014from physicochemical properties to biomedical applications: a modern insight on the ancient drug. Int J Pharm. 2019;559:271\u20139.","journal-title":"Int J Pharm"},{"issue":"18","key":"1165_CR10","doi-asserted-by":"crossref","first-page":"20995","DOI":"10.1021\/acsami.1c02755","volume":"13","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Xiao Y, Xu L, Liu Y, Jiang G, Wang W, et al. Glycyrrhizic acid nanoparticles as antiviral and anti-inflammatory agents for COVID-19 treatment. ACS Appl Mater Interfaces. 2021;13(18):20995\u20131006.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"4","key":"1165_CR11","first-page":"2042","volume":"11","author":"L Qu","year":"2019","unstructured":"Qu L, Chen C, He W, Chen Y, Li Y, Wen Y, et al. Glycyrrhizic acid ameliorates LPS-induced acute lung injury by regulating autophagy through the PI3K\/AKT\/mTOR pathway. Am J Transl Res. 2019;11(4):2042\u201355.","journal-title":"Am J Transl Res"},{"key":"1165_CR12","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jcis.2021.03.101","volume":"598","author":"I Tucker","year":"2021","unstructured":"Tucker I, Burley A, Petkova R, Hosking S, Penfold J, Thomas R, et al. Adsorption and self-assembly properties of the plant based biosurfactant, Glycyrrhizic acid. J Colloid Interface Sci. 2021;598:444\u201354.","journal-title":"J Colloid Interface Sci"},{"issue":"3","key":"1165_CR13","first-page":"307","volume":"34","author":"Y Wang","year":"2009","unstructured":"Wang Y, Yang M, Ma Z, Liang Q, Tan H, Xiao C, Gao Y, et al. Effects of 18beta-glycyrrhizic acid and 18alpha-glycyrrhizic acid on mRNA and protein expression of cytochrome P450 3A in cultured rat primary hepatocyte. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China J Chin Mater Med. 2009;34(3):307\u201311.","journal-title":"Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China J Chin Mater Med"},{"key":"1165_CR14","doi-asserted-by":"crossref","first-page":"681525","DOI":"10.3389\/fphar.2021.681525","volume":"12","author":"Y Feng","year":"2021","unstructured":"Feng Y, Mei L, Wang M, Huang Q, Huang R. In vitroanti-inflammatory and pro-apoptotic effects of 18beta-glycyrrhetinic acid and models of rheumatoid arthritis. Front Pharmacol. 2021;12:681525.","journal-title":"Front Pharmacol"},{"issue":"6","key":"1165_CR15","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1039\/C7MD00063D","volume":"8","author":"E Pavadai","year":"2017","unstructured":"Pavadai E, Kaur G, Wittlin S, Chibale K. Identification of steroid-like natural products as antiplasmodial agents by 2D and 3D similarity-based virtual screening. MedChemComm. 2017;8(6):1152\u20137.","journal-title":"MedChemComm"},{"issue":"4","key":"1165_CR16","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s10753-015-0140-2","volume":"38","author":"C Xie","year":"2015","unstructured":"Xie C, Li X, Wu J, Liang Z, Deng F, Xie W, et al. Anti-inflammatory activity of magnesium isoglycyrrhizinate through inhibition of phospholipase A2\/arachidonic acid pathway. Inflammation. 2015;38(4):1639\u201348.","journal-title":"Inflammation"},{"key":"1165_CR17","doi-asserted-by":"crossref","first-page":"109702","DOI":"10.1016\/j.biopha.2019.109702","volume":"125","author":"X Cheng","year":"2020","unstructured":"Cheng X, Qiu L, Wang F. 18\u03b1-Glycyrrhetinic acid (GA) ameliorates fructose-induced nephropathy in mice by suppressing oxidative stress, dyslipidemia and inflammation. Biomed Pharmacother. 2020;125:109702.","journal-title":"Biomed Pharmacother"},{"issue":"43","key":"1165_CR18","doi-asserted-by":"crossref","first-page":"9938","DOI":"10.1021\/acs.jpcb.8b07989","volume":"122","author":"E Shelepova","year":"2018","unstructured":"Shelepova E, Kim A, Voloshin V, Medvedev N. Intermolecular voids in lipid bilayers in the presence of glycyrrhizic acid. J Phys Chem B. 2018;122(43):9938\u201346.","journal-title":"J Phys Chem B"},{"key":"1165_CR19","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.colsurfb.2016.08.037","volume":"147","author":"O Selyutina","year":"2016","unstructured":"Selyutina O, Apanasenko I, Kim A, Shelepova E, Khalikov S, Polyakov N. Spectroscopic and molecular dynamics characterization of glycyrrhizin membrane-modifying activity. Colloids Surf, B Biointerfaces. 2016;147:459\u201366.","journal-title":"Colloids Surf, B Biointerfaces"},{"key":"1165_CR20","doi-asserted-by":"crossref","first-page":"172550","DOI":"10.1016\/j.ejphar.2019.172550","volume":"859","author":"Z Yin","year":"2019","unstructured":"Yin Z, Zhu W, Wu Q, Zhang Q, Guo S, Liu T, et al. Glycyrrhizic acid suppresses osteoclast differentiation and postmenopausal osteoporosis by modulating the NF-\u03baB, ERK, and JNK signaling pathways. Eur J Pharmacol. 2019;859:172550.","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"1165_CR21","doi-asserted-by":"crossref","first-page":"12567","DOI":"10.1021\/acsnano.1c02103","volume":"15","author":"S Gao","year":"2021","unstructured":"Gao S, Yang X, Xu J, Qiu N, Zhai G. Nanotechnology for boosting cancer immunotherapy and remodeling tumor microenvironment: the horizons in cancer treatment. ACS Nano. 2021;15:12567\u2013603.","journal-title":"ACS Nano"},{"key":"1165_CR22","doi-asserted-by":"crossref","first-page":"113264","DOI":"10.1016\/j.bios.2021.113264","volume":"190","author":"P Song","year":"2021","unstructured":"Song P, Fu H, Wang Y, Chen C, Ou P, Rashid R, et al. A microfluidic field-effect transistor biosensor with rolled-up indium nitride microtubes. Biosens Bioelectron. 2021;190:113264.","journal-title":"Biosens Bioelectron"},{"issue":"1","key":"1165_CR23","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1038\/s41467-021-23959-3","volume":"12","author":"B Kim","year":"2021","unstructured":"Kim B, Soepriatna A, Park W, Moon H, Cox A, Zhao J, et al. Rapid custom prototyping of soft poroelastic biosensor for simultaneous epicardial recording and imaging. Nat Commun. 2021;12(1):3710.","journal-title":"Nat Commun"},{"key":"1165_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202101460","author":"G Li","year":"2021","unstructured":"Li G, Sun B, Li Y, Luo C, He Z, Sun J. Small-molecule prodrug nanoassemblies: an emerging nanoplatform for anticancer drug delivery. Small. 2021. https:\/\/doi.org\/10.1002\/smll.202101460.","journal-title":"Small"},{"key":"1165_CR25","doi-asserted-by":"crossref","first-page":"10331","DOI":"10.2147\/IJN.S281029","volume":"15","author":"S Yang","year":"2020","unstructured":"Yang S, Huang C, Wang C, Shieh M, Chen K. The synergistic effect of hyperthermia and chemotherapy in magnetite nanomedicine-based lung cancer treatment. Int J Nanomed. 2020;15:10331\u201347.","journal-title":"Int J Nanomed"},{"issue":"32","key":"1165_CR26","doi-asserted-by":"crossref","first-page":"38114","DOI":"10.1021\/acsami.1c11017","volume":"13","author":"Y Sun","year":"2021","unstructured":"Sun Y, Cao J, Wang X, Zhang C, Luo J, Zeng Y, et al. Hypoxia-adapted sono-chemodynamic treatment of orthotopic pancreatic carcinoma using copper metal-organic frameworks loaded with an ultrasound-induced free radical initiator. ACS Appl Mater Interfaces. 2021;13:38114\u201326.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1165_CR27","doi-asserted-by":"crossref","first-page":"37713","DOI":"10.1021\/acsami.1c10816","volume":"13","author":"H Peng","year":"2021","unstructured":"Peng H, Qin Y, Feng Y, He X, Li W, Zhang Y. Phosphate-degradable nanoparticles based on metal-organic frameworks for chemo-starvation-chemodynamic synergistic antitumor therapy. ACS Appl Mater Interfaces. 2021;13:37713\u201323.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1165_CR28","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jconrel.2019.02.039","volume":"300","author":"P Li","year":"2019","unstructured":"Li P, Chen X, Shen Y, Li H, Zou Y, Yuan G, et al. Mucus penetration enhanced lipid polymer nanoparticles improve the eradication rate of Helicobacter pylori biofilm. J Control Release. 2019;300:52\u201363.","journal-title":"J Control Release"},{"issue":"30","key":"1165_CR29","doi-asserted-by":"crossref","first-page":"e2001808","DOI":"10.1002\/adma.202001808","volume":"32","author":"Y Jiang","year":"2020","unstructured":"Jiang Y, Krishnan N, Zhou J, Chekuri S, Wei X, Kroll A, et al. Engineered cell-membrane-coated nanoparticles directly present tumor antigens to promote anticancer immunity. Adv Mater (Deerfield Beach, Fla). 2020;32(30):e2001808.","journal-title":"Adv Mater (Deerfield Beach, Fla)"},{"issue":"1","key":"1165_CR30","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12951-021-00949-7","volume":"19","author":"P Wu","year":"2021","unstructured":"Wu P, Jiang X, Yin S, Yang Y, Liu T, Wang K. Biomimetic recombinant of red blood cell membranes for improved photothermal therapy. J Nanobiotechnol. 2021;19(1):213.","journal-title":"J Nanobiotechnol"},{"key":"1165_CR31","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.biomaterials.2016.10.003","volume":"111","author":"X Wei","year":"2016","unstructured":"Wei X, Gao J, Fang RH, Luk BT, Kroll AV, Dehaini D, et al. Nanoparticles camouflaged in platelet membrane coating as an antibody decoy for the treatment of immune thrombocytopenia. Biomaterials. 2016;111:116\u201323.","journal-title":"Biomaterials"},{"key":"1165_CR32","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jconrel.2021.05.031","volume":"335","author":"Y Li","year":"2021","unstructured":"Li Y, Wu H, Jiang X, Zhang T, Zhou Y, Huang L, et al. Active stealth and self-positioning biomimetic vehicles achieved effective antitumor therapy. J Control Release. 2021;335:515\u201326.","journal-title":"J Control Release"},{"issue":"7571","key":"1165_CR33","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature15373","volume":"526","author":"CM Hu","year":"2015","unstructured":"Hu CM, Fang RH, Wang KC, Luk BT, Thamphiwatana S, Dehaini D, et al. Nanoparticle biointerfacing by platelet membrane cloaking. Nature. 2015;526(7571):118\u201321.","journal-title":"Nature"},{"key":"1165_CR34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.coph.2019.03.012","volume":"46","author":"S Pitchford","year":"2019","unstructured":"Pitchford S, Cleary S, Arkless K, Amison R. Pharmacological strategies for targeting platelet activation in asthma. Curr Opin Pharmacol. 2019;46:55\u201364.","journal-title":"Curr Opin Pharmacol"},{"key":"1165_CR35","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.etap.2016.06.016","volume":"45","author":"Y Wang","year":"2016","unstructured":"Wang Y, Zhu H, Tong J, Li Z. Ligustrazine improves blood circulation by suppressing Platelet activation in a rat model of allergic asthma. Environ Toxicol Pharmacol. 2016;45:334\u20139.","journal-title":"Environ Toxicol Pharmacol"},{"issue":"4","key":"1165_CR36","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1021\/jf505471a","volume":"63","author":"C Wu","year":"2015","unstructured":"Wu C, Chen A, Yen G. Protective effects of glycyrrhizic acid and 18\u03b2-glycyrrhetinic acid against cisplatin-induced nephrotoxicity in BALB\/c mice. J Agric Food Chem. 2015;63(4):1200\u20139.","journal-title":"J Agric Food Chem"},{"issue":"9","key":"1165_CR37","doi-asserted-by":"crossref","first-page":"15026","DOI":"10.3390\/ijms150915026","volume":"15","author":"S Hou","year":"2014","unstructured":"Hou S, Zheng F, Li Y, Gao L, Zhang J. The protective effect of glycyrrhizic acid on renal tubular epithelial cell injury induced by high glucose. Int J Mol Sci. 2014;15(9):15026\u201343.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1165_CR38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.taap.2014.01.013","volume":"276","author":"D Aguilar","year":"2014","unstructured":"Aguilar D, Strom J, Chen Q. Glucocorticoid induced leucine zipper inhibits apoptosis of cardiomyocytes by doxorubicin. Toxicol Appl Pharmacol. 2014;276(1):55\u201362.","journal-title":"Toxicol Appl Pharmacol"},{"key":"1165_CR39","doi-asserted-by":"crossref","first-page":"131604","DOI":"10.1155\/2014\/131604","volume":"2014","author":"C Liang","year":"2014","unstructured":"Liang C, Wu J, Lai J, Ye S, Lin J, Ouyang H, et al. Protection effect of Zhen-Wu-Tang on adriamycin-induced nephrotic syndrome via inhibiting oxidative lesions and inflammation damage. Evid-Based Complement Altern Med. 2014;2014:131604.","journal-title":"Evid-Based Complement Altern Med"},{"issue":"15","key":"1165_CR40","doi-asserted-by":"crossref","first-page":"eabe6374","DOI":"10.1126\/sciadv.abe6374","volume":"7","author":"Y Wei","year":"2021","unstructured":"Wei Y, Yan L, Luo L, Gui T, Jang B, Amirshaghaghi A, et al. Phospholipase A inhibitor-loaded micellar nanoparticles attenuate inflammation and mitigate osteoarthritis progression. Sci Adv. 2021;7(15):eabe6374.","journal-title":"Sci Adv"},{"issue":"32","key":"1165_CR41","doi-asserted-by":"crossref","first-page":"16494","DOI":"10.1074\/jbc.M116.722017","volume":"291","author":"S Mortensen","year":"2016","unstructured":"Mortensen S, Jensen J, Andersen G. Solution structures of complement C2 and its C4 complexes propose pathway-specific mechanisms for control and activation of the complement proconvertases. J Biol Chem. 2016;291(32):16494\u2013507.","journal-title":"J Biol Chem"},{"key":"1165_CR42","doi-asserted-by":"crossref","first-page":"607635","DOI":"10.3389\/fphar.2021.607635","volume":"12","author":"J Bai","year":"2021","unstructured":"Bai J, Xu J, Hang K, Kuang Z, Ying L, Zhou C, et al. Glycyrrhizic acid promotes osteogenic differentiation of human bone marrow stromal cells by activating the Wnt\/\u03b2-catenin signaling pathway. Front Pharmacol. 2021;12:607635.","journal-title":"Front Pharmacol"},{"issue":"3","key":"1165_CR43","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s00774-012-0413-x","volume":"31","author":"E Ramli","year":"2013","unstructured":"Ramli E, Suhaimi F, Asri S, Ahmad F, Soelaiman I. Glycyrrhizic acid (GCA) as 11\u03b2-hydroxysteroid dehydrogenase inhibitor exerts protective effect against glucocorticoid-induced osteoporosis. J Bone Miner Metab. 2013;31(3):262\u201373.","journal-title":"J Bone Miner Metab"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-021-01165-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-021-01165-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-021-01165-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T09:22:32Z","timestamp":1726305752000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-021-01165-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1165"],"URL":"https:\/\/doi.org\/10.1186\/s12951-021-01165-z","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"29 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors obtained authorization to perform the tests on animal from the committee of Third\u00a0Xiangya Hospital of Central South University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"417"}}